Abstract:DDX17 is a member of the DEAD-Box helicase family proteins involved in cellular RNA folding, splicing, and translation. It has been reported that DDX17 serves as a co-factor of host zinc finger antiviral protein (ZAP)-mediated retroviral RNA degradation and exerts direct antiviral function against Raft Valley Fever Virus though binding to specific stem-loop structures of viral RNA. Intriguingly, we have previously shown that ZAP inhibits Hepatitis B virus (HBV) replication through promoting viral RNA decay, and the ZAP-responsive element (ZRE) of HBV pregenomic RNA (pgRNA) contains a stem-loop structure, specifically epsilon, which serves as the packaging signal for pgRNA encapsidation. In this study, we demonstrated that the endogenous DDX17 is constitutively expressed in human hepatocyte-derived cells but dispensable for ZAP-mediated HBV RNA degradation. However, DDX17 was found to inhibit HBV replication primarily by reducing the level of cytoplasmic encapsidated pgRNA in a helicase-dependent manner. Immunofluorescence assay revealed that DDX17 could gain access to cytoplasm from nucleus in the presence of HBV RNA. In addition, RNA immunoprecipitation and electrophoretic mobility shift assays demonstrated that the enzymatically active DDX17 competes with HBV polymerase to bind to pgRNA at the 5' epsilon motif. In summary, our study suggests that DDX17 serves as an intrinsic host restriction factor against HBV through interfering with pgRNA encapsidation. IMPORTANCE Hepatitis B virus (HBV) chronic infection, a long-studied but yet incurable disease, remains a major public health concern worldwide. Given that HBV replication cycle highly depends on host factors, deepening our understanding of the host-virus interaction is thus of great significance in the journey of finding a cure. In eukaryotic cells, RNA helicases of DEAD-box family are highly conserved enzymes involved in diverse processes of cellular RNA metabolism. Emerging data have shown that DDX17, a typical member of DEAD box family, functions as an antiviral factor through interacting with viral RNA. In this study, we, for the first time, demonstrate that DDX17 inhibits HBV through blocking the formation of viral replication complex, which not only broadens the antiviral spectrum of DDX17, but also provides new insight into the molecular mechanism of DDX17-mediated virus-host interaction.

RNA-Binding Motif Protein 24 (RBM24) is Involved in Pregenomic RNA Packaging by Mediating Interaction Between Hepatitis B Virus Polymerase and the Epsilon Element

RBM24 Stabilizes Hepatitis B Virus Pregenomic RNA but Inhibits Core Protein Translation by Targeting the Terminal Redundancy Sequence.

RNA-Binding Motif Protein 38 (RBM38) Mediates HBV Pgrna Packaging into the Nucleocapsid.

RNA-binding motif protein 24 inhibits HBV replication in vivo.

RNA binding protein 24 regulates the translation and replication of hepatitis C virus

RBM24 inhibits the translation of SARS-CoV-2 polyproteins by targeting the 5'-untranslated region

G-quadruplex in hepatitis B virus pregenomic RNA promotes its translation

Identification of Host Proteins Involved in Hepatitis B Virus Genome Packaging

[The Mechanisms of the Translation of Polymerase from HBV Pregenomic RNA].

Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis

Hepatitis B virus RNAs co-opt ELAVL1 for stabilization and CRM1-dependent nuclear export

[Post-transcriptional regulation mechanism and antiviral strategy of hepatitis B virus RNA]

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

RNA Helicase DDX17 inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation

Exploiting New Potential Targets for Anti-Hepatitis B Virus Drugs.

Hepatitis B virus core protein phosphorylation: Identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure

Effect of Pregenomic RNA on the Mechanical Stability of HBV Capsid by Coarse-Grained Molecular Simulations

Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus

Functional Characterization of Hepatitis B Virus Core Promoter Mutants Revealed Transcriptional Interference among Co-Terminal Viral Mrnas.

TRPV4 promotes HBV replication and capsid assembly via methylation modification of H3K4 and HBc ubiquitin

RPB5-Mediating Protein Suppresses Hepatitis B Virus (HBV) Transcription and Replication by Counteracting the Transcriptional Activation of Hepatitis B Virus X Protein in HBV Replication Mouse Model.